Resultados da busca - Roland Greinwald
- Mostrando 1 - 19 resultados de 19
-
1
Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon – a placebo‐controlled study por Wolfgang Kruis, Eberhard Meier, M. Schumacher, O Mickisch, Roland Greinwald, Ralph Müeller
Publicado em 2013Artigo -
2
Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial por Wolfgang Kruis, Gediminas Kiudelis, I Rácz, I A Gorelov, Juris Pokrotnieks, M. Horyński, M Bátovský, Jan Kykal, S. A. Boehm, Roland Greinwald, Ralph Müeller
Publicado em 2008Artigo -
3
Peripheral blood eosinophils and other non‐invasive biomarkers can monitor treatment response in eosinophilic oesophagitis por Christoph Schlag, Stephan Miehlke, Alexander Heiseke, Knut Brockow, Anne Krug, Ulrike von Arnim, Alex Straumann, Michael Vieth, Christian Bussmann, Ralph Müeller, Roland Greinwald, Monther Bajbouj
Publicado em 2015Artigo -
4
3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial por Volker Groß, Ivan Bunganič, E. А. Belousova, Т. Л. Михайлова, Limas Kupčinskas, Gediminas Kiudelis, Zsolt Tulassay, Libor Gabalec, Andrey Dorofeyev, Jeļena Derova, Karin Dilger, Roland Greinwald, Ralph Müeller
Publicado em 2010Artigo -
5
Budesonide Is More Effective Than Mesalamine or Placebo in Short-term Treatment of Collagenous Colitis por Stephan Miehlke, Ahmed Madisch, Limas Kupčinskas, Dalius Petrauskas, Günter Böhm, Hans-Joachim Marks, Michael Neumeyer, Torben Nathan, Fernando Fernández‐Bañares, Roland Greinwald, Ralf Mohrbacher, Michael Vieth, Ole K. Bonderup
Publicado em 2014Artigo -
6
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a ran... por Walter Reinisch, Sieglinde Angelberger, Wolfgang Petritsch, Olga Shonová, Milan Lukáš, Simon Bar–Meir, Alexander Teml, Elke Schaeffeler, Matthias Schwab, K. Dilger, Roland Greinwald, Ralph Müeller, Eduard F. Stange, Klaus R. Herrlinger
Publicado em 2010Artigo -
7
A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA por Gideon M. Hirschfield, Ulrich Beuers, Limas Kupčinskas, Peter Ott, Annika Bergquist, Martti Färkkilâ, Michael P. Manns, Albert Parés, Ulrich Spengler, Michael Stieß, Roland Greinwald, Markus Pröls, Dominique Wendum, Uta Drebber, Raoul Poupon
Publicado em 2020Artigo -
8
Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis por Volker Groß, Simon Bar–Meir, Alexandra Lavy, O Mickisch, Zsolt Tulassay, Laszio Pronai, Limas Kupčinskas, Gediminas Kiudelis, Juris Pokrotnieks, Ágota Kovács, M. Faszczyk, Artūras Razbadauskas, Benno Margus, M. Stolte, Rudolf Müller, Roland Greinwald
Publicado em 2005Artigo -
9
A Randomised, Double-blind, Placebo-controlled Trial of<i>Trichuris suis</i>ova in Active Crohn’s disease por Jürgen Schölmerich, Klaus Fellermann, Frank Seibold, Gerhard Rogler, Jost Langhorst, Stefanie Howaldt, Gottfried Novacek, Andreas Munk Petersen, Oliver Bachmann, Harald Matthes, Norbert Hesselbarth, Niels Teich, Jan Wehkamp, Jochen Klaus, Claudia Ott, Karin Dilger, Roland Greinwald, Ralph Müeller
Publicado em 2016Artigo -
10
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme por Stephan Miehlke, Christoph Schlag, Alfredo J. Lucendo, Luc Biedermann, Cecílio Santander, Christoph Schmoecker, Jamal Hayat, Petr Hrúz, Constanza Ciriza de los Ríos, Albert J. Bredenoord, Michael Vieth, Alain Schoepfer, Stephen Attwood, Ralph Müeller, Sarah Burrack, Roland Greinwald, Alex Straumann
Publicado em 2022Artigo -
11
A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis por Stephan Miehlke, Petr Hrúz, Michael Vieth, Christian Bussmann, Ulrike von Arnim, Monther Bajbouj, Christoph Schlag, Ahmed Madisch, Christiane Fibbe, Henning Wittenburg, Hans D. Allescher, Max Reinshagen, Stefan Schubert, Jan Tack, Michaela Müller, Patrick Krummenerl, Joris Arts, Ralph Müeller, Karin Dilger, Roland Greinwald, Alex Straumann
Publicado em 2015Artigo -
12
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis por Peter Fickert, Gideon M. Hirschfield, Gerald Denk, Hanns‐Ulrich Marschall, I Altorjay, Martti Färkkilâ, Christoph Schramm, Ulrich Spengler, R W Chapman, Annika Bergquist, Erik Schrumpf, Frederik Nevens, Palak Trivedi, Florian P. Reiter, István Tornai, Emina Halilbasic, Roland Greinwald, Markus Pröls, Michael P. Manns, Michael Trauner
Publicado em 2017Artigo -
13
Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial por Andreas Münch, Johan Bohr, Stephan Miehlke, Cecilia Benoni, Martin Olesen, Åke Öst, Lars Strandberg, Per M. Hellström, Erik Hertervig, Peter Armerding, Jiřı́ Stehlı́k, Greger Lindberg, Jan Björk, Annika Lapidus, Robert Löfberg, Ole K. Bonderup, Søren Avnstrøm, Martin Rössle, Karin Dilger, Ralph Müeller, Roland Greinwald, Curt Tysk, Magnus Ström
Publicado em 2014Artigo -
14
Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence por Wolfgang Kruis, Vassilios Kardalinos, Thomas Eisenbach, Milan Lukáš, Tomás Vich, Ivan Bunganič, Juris Pokrotnieks, Jeļena Derova, Jūratė Kondrackienė, Rifaat Safadi, Daniel Tuculanu, Zsolt Tulassay, J Banai, A. Curtin, A.E. Dorofeyev, Salam Zakko, Nicola Ferreira, S Björck, Manuel Díez‐Alonso, Jyrki Mäkelä, Nicholas J. Talley, K. Dilger, Roland Greinwald, Ralf Mohrbacher, Robert E. Spiller
Publicado em 2017Artigo -
15
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease por Detlef Schuppan, Markku Mäki, Knut E.A. Lundin, Jorma Isola, Tina Friesing-Sosnik, Juha Taavela, Alina Popp, Jari Koskenpato, Jost Langhorst, Øistein Hovde, Marja‐Leena Lähdeaho, Stefano Fusco, Michael Schümann, Helga‐Paula Török, Juozas Kupčinskas, Yurdagül Zopf, Ansgar W. Lohse, Mika Scheinin, Karin Kull, Luc Biedermann, Valerie Byrnes, Andreas Stallmach, Jørgen Jahnsen, Jonas Zeitz, Ralf Mohrbacher, Roland Greinwald
Publicado em 2021Artigo -
16
Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease por Valeriia Dotsenko, Bernhard Tewes, Martin Hils, Ralf Pasternack, Jorma Isola, Juha Taavela, Alina Popp, Jani Sarin, Heini Huhtala, Pauliina Hiltunen, Timo Zimmermann, Ralf Mohrbacher, Roland Greinwald, Knut E.A. Lundin, Detlef Schuppan, Markku Mäki, Keijo Viiri, Karin Kull, Jari Koskenpato, Mika Scheinin, Marja‐Leena Lähdeaho, Michael Schümann, Yurdagül Zopf, Andreas Stallmach, Ansgar W. Lohse, Stefano Fusco, Jost Langhorst, Helga‐Paula Török, Valerie Byrnes, Juozas Kupčinskas, Øistein Hovde, Jørgen Jahnsen, Luc Biedermann, Jonas Zeitz
Publicado em 2024Artigo -
17
Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis por Stephan Miehlke, Daniela E. Aust, Emese Mihály, Peter Armerding, G. Böhm, Ole K. Bonderup, Fernando Fernández‐Bañares, Juozas Kupčinskas, Lars Kristian Munck, Kai-Uwe Rehbehn, Tanju Nacak, Roland Greinwald, Andreas Münch, Jiri Stehlk, Ole K. Bonderup, Lars Kristian Munck, T. Rannem, Peter Armerding, Michael Bläker, Günter Böhm, M Hoesl, Christian Kirsch, Ahmed Madisch, Eberhard Meier, Stephan Miehlke, Kai-Uwe Rehbehn, G Kiss, Ferenc Nagy, Zsolt Tulassay, F Zsigmond, Limas Kupčinskas, Gerd Bouma, Marieke Pierik, Fernando Fernández‐Bañares, Alfredo J. Lucendo, Johan Bohr, Per M. Hellström, Barbro Lebrun, Greger Lindberg, Andreas Münch, Lina Vigren, M Wielondek, Martin Krauß, Axel Dignaß, Wolfgang Kruis
Publicado em 2018Artigo -
18
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis por Alex Straumann, Alfredo J. Lucendo, Stephan Miehlke, Michael Vieth, Christoph Schlag, Luc Biedermann, Cecílio Santander, Constanza Ciriza de los Ríos, Christoph Schmoecker, Ahmed Madisch, Petr Hrúz, Jamal Hayat, Ulrike von Arnim, Albert J. Bredenoord, Stefan Schubert, Ralph Müeller, Roland Greinwald, Alain Schoepfer, Stephen Attwood, Jan Tack, Stephan Miehlke, Monther Bajbouj, Stefan Brückner, Christiane Fibbe, Sebastian Haag, Christoph Schmöcker, Dirk Hartmann, Frank Lammert, Ahmed Madisch, Max Reinshagen, Stefan Schubert, Ulrike von Arnim, Norbert Börner, Dieter Witzemann, Karel Caca, Jörg Albert, Stefan Zeuzem, Felix Wiedbrauck, Helmut Messmann, Albert J. Bredenoord, Robert C. Verdonk, Franciscus Wolfhagen, Alfredo Lucendo Villarin, Cecílio Santander, Constanza Ciriza de los Ríos, Antonia Perelló Juan, Isabel Pérez‐Martínez, Joaquín Rodríguez Sánchez-Migallón, Jesús Barrio, ÁngelesPérez Aisa, Alex Straumann, Petr Hrúz, Alain Schoepfer, Luc Biedermann, Jamal Hayat, Anjan Dhar
Publicado em 2020Artigo -
19
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial por Alfredo J. Lucendo, Stephan Miehlke, Christoph Schlag, Michael Vieth, Ulrike von Arnim, Javier Molina‐Infante, Dirk Hartmann, Albert J. Bredenoord, Constanza Ciriza de los Ríos, Stefan Schubert, Stefan Brückner, Ahmed Madisch, Jamal Hayat, Jan Tack, Stephen Attwood, Ralph Müeller, Roland Greinwald, Alain Schoepfer, Alex Straumann, Jan Tack, Tim Vanuytsel, Hubert Louis, Carmen Musala, Stephan Miehlke, Dorothea Frederking, Monther Bajbouj, Christoph Schlag, Simon Nennstiel, Stefan Brückner, Renate Schmelz, Schmelz Heimerl, Anna-Magdalena Stephan, Christiane Fibbe, Niels Liedtke, Jutta Keller, Ulrich Rosien, Sebastian Haag, A Schneider, Dirk Hartmann, Christoph Schmöcker, Hendrik Buchholz, Frank Lammert, Markus Casper, Matthias Reichert, Ahmed Madisch, D. Sommer, Hubert Mönnikes, Miriam Stengel, M. Schmidtmann, Michaela Müller, Alexander J. Eckardt, Till Wehrmann, Stefan Schubert, Peter Armerding, Wolf Peter Hofmann, Thomas Liceni, Ulrike von Arnim, Arne Kandulski, Jochen Weigt, Norbert Börner, A. Lutz-Vorderbrügge, Jörg Albert, Stefan Zeuzem, Irina Blumenstein, Kathrin Sprinzl, Johannes Hausmann, Arjan Bredenoord, Arjan Bredenoord, Marijn J. Warners, Alfredo Lucendo Villarin, Ángel Arias, Maria Ángeles Tejero Bustos, María Jesús Carrillo Ramos, J.M. Gallardo, Rocío Juárez Tosina, Javier Molina‐Infante, Josè Luis Zamorano, Cecílio Santander, Sergio Casabona, Maria T. Perez, Teresa Rodríguez, Constanza Ciriza de los Ríos, Fernando Canga Rodríguez‐Valcárcel, Isabel Castel de Lucas, Antonia Perelló Juan, Mercè Barenys, Carlos Casasnovas, Isabel Pérez‐Martínez, M. Eugenia Lauret, Andrés Castaño García, Esmeralda Rubio, Alex Straumann, Petr Hrúz, Simon Brunner, Jamal Hayat, Andrew Poullis
Publicado em 2019Artigo
Ferramentas de busca:
Assuntos relacionados
Internal medicine
Medicine
Gastroenterology
Disease
Alternative medicine
Pathology
Placebo
Budesonide
Randomized controlled trial
Clinical endpoint
Corticosteroid
Mesalazine
Surgery
Adverse effect
Asthma
Inflammatory bowel disease
Double blind
Eosinophilic esophagitis
Ulcerative colitis
Biochemistry
Biology
Clinical trial
Colitis
Enzyme
Immunology
Placebo-controlled study
Collagenous colitis
Crohn's disease
Environmental health
Gene